A Translational Investigation Of Ifn-Alpha And Stat1 Signaling In Endothelial Cells During Septic Shock Provides Therapeutic Perspectives

Septic shock and disseminated intravascular coagulation (DIC) arc known to be characterized by an endothelial cell dysfunction. The molecular mechanisms underlying this relationship are, however, poorly understood. In this work, we aimed to investigate human circulating IFN-alpha in patients with septic shock-induced DIC and tested the potential role of endothelial Stat1 (signal transducer and activator of transcription 1) as a therapeutic target in a mouse model of sepsis. For this, circulating type I, type II, and type III IFNs and procoagulant microvesides were quantified in a prospective cohort of patients with septic shock. Next, we used a septic shock model induced by cecal ligation and puncture in wild-type mice, in Ifnarl (type I IFN receptor subunit 1)-knockout mice, and in Stall conditional knockout mice. In human samples, we observed higher concentrations of circulating IFN-a and IFN-al in patients with DIC compared with patients without DIC, whereas concentrations of IFN-beta, IFN-gamma, IFN-lambda 1, IFN-X2, and IFN-lambda 3 were not different. IFN-a concentration was positively correlated with CD105 microvesicle concentrations, reflecting endothelial injury. In Ifnarl mice, cecal ligation and puncture did not induce septic shock and was characterized by lesser endothelial cell injury, with lower aortic inflammatory cytokine expression, endothelial inflammatory-related gene expression, and fibrinolysis. In mice in which Stat1 was specifically ablated in endothelial cells, a marked protection against sepsis was also observed, suggesting the relevance of an endothelium-targeted strategy. Our work highlights the key roles of type I IFNs as pathogenic players in septic shock-induced DIC and the potential pertinence of endothelial STAT1 as a therapeutic target.